论文部分内容阅读
贫血是慢性肾脏病患者的常见并发症,基因重组人类促红细胞生成素(rHuEPO)的应用使肾性贫血的治疗有了很大的改观,但疗效尚不能完全令人满意。我们从2007年7月至2008年12月在使用rHuEPO和口服铁剂、叶酸及维生素B12的基础上加用自拟补肾健脾化浊养血汤治疗肾性贫血,取得了较满意的疗效。1对象与方法1.1对象50例患者均为我院血液净化中心维持性血液透析患者,男31例,女29例,年龄(56.71±11.38)岁,透析龄3个月～8年,平均(30.2±22.3)月。在原发病中,慢性肾小球
Anemia is a common complication in patients with chronic kidney disease. The use of recombinant human erythropoietin (rHuEPO) has greatly improved the treatment of renal anemia, but the effect is not yet entirely satisfactory. We from July 2007 to December 2008 in the use of rHuEPO and oral iron, folic acid and vitamin B12 based on the use of self Bushen Jianpi Huzun Yangxue Tang treatment of renal anemia, and achieved satisfactory results. 1 Subjects and Methods 1.1 Subjects 50 patients were maintenance hemodialysis patients in our hospital blood purification center, 31 males and 29 females, aged (56.71 ± 11.38) years of age, dialysis age 3 months to 8 years, the average (30.2 ± 22.3) months. In the primary disease, chronic glomeruli